Witnessing the stock’s movement on the chart, on Thursday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) set off with pace as it heaved 1.44% to $7.73, before
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) on Friday, soared 5.52% from the previous trading day, before settling in for the closing price of $7.06. Within the
A new trading day began on Friday, with Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) stock price down -4.72% from the previous day of trading, before settling
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) open the trading on Tuesday, with a bit cautious approach as it glided -0.13% to $7.52, before settling in for
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) established initial surge of 0.65% at $7.72, before settling in for the price of $7.67 at the close. Taking a
On Friday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) was 2.44% up from the session before settling in for the closing price of $7.39. A 52-week range
On Friday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) opened lower -0.92% from the last session, before settling in for the closing price of $7.60. Price fluctuations
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) on Tuesday, soared 2.59% from the previous trading day, before settling in for the closing price of $7.73. Within the
On Tuesday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) was -2.57% drop from the session before settling in for the closing price of $7.38. A 52-week range
On Monday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) opened lower -4.34% from the last session, before settling in for the closing price of $7.60. Price fluctuations
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
